Cargando…
Case report: Recurrent angioedema: Diagnosing the rare and the frequent
Hereditary angiodema with normal C1 inhibitor and unknown mutation (HAE-nC1INH-UNK), an exceedingly rare subtype of HAE, appears to be often diagnosed in patients who do not have this condition, but have mast cell-mediated angioedema. Here, we report two patients diagnosed with HAE-nC1INH-UNK by the...
Autores principales: | Buttgereit, Thomas, Fijen, Lauré M., Vera, Carolina, Bergmann, Karl-Christian, Maurer, Marcus, Magerl, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756157/ https://www.ncbi.nlm.nih.gov/pubmed/36530887 http://dx.doi.org/10.3389/fmed.2022.1048480 |
Ejemplares similares
-
Sensitivity to change and minimal clinically important difference of the angioedema control test
por: Fijen, Lauré M., et al.
Publicado: (2023) -
Patient‐physician interactions in hereditary angioedema—Key learnings from the coronavirus disease 2019 pandemic
por: Maurer, Marcus, et al.
Publicado: (2023) -
Differences and Similarities in the Mechanisms and Clinical Expression of Bradykinin-Mediated vs. Mast Cell–Mediated Angioedema
por: Maurer, Marcus, et al.
Publicado: (2021) -
COVID-19 vaccination and the risk of swellings in patients with hereditary angioedema
por: Fijen, Lauré M., et al.
Publicado: (2021) -
Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies
por: Aygören-Pürsün, Emel, et al.
Publicado: (2018)